A suitable pharmacare program would be a publicly funded and administered system that provides coverage for prescription drugs to all Canadians.
If the legislation is passed but not fully implemented by the end of 2025, the market will still resolve as YES.
Update 2025-05-17 (PST) (AI summary of creator comment): A program that provides coverage for some prescription drugs to all Canadians (such as the initial phase described in Bill C-64) will count for a YES resolution. It is not required that the program cover all prescription drugs.
@kenakofer Hi. Given that C-64 passed, becoming the Pharmacare Act, does that mean this market will resolve YES? At this time the program has not been not fully implemented, and doesn't cover many drugs, but fortunately you've already clarified that that won't prevent a Yes.
Hi! What happens if Bill C-64 passes, which will provide coverage for some prescription drugs to all Canadians -- but not ALL prescription drugs? https://www.canada.ca/en/health-canada/news/2024/02/government-of-canada-introduces-legislation-for-first-phase-of-national-universal-pharmacar.html
@Lexer Yeah. It will be too hard for me to adjudicate more complicated conditions. Feel free to link markets with other conditions
@kenakofer your market requires certain features of the pharmacare legislation, like public funding. My only requirement is that the NDP vote for it (and it passes).